Year None2024202320222021202020192018 Sensei Biotherapeutics to Participate in Citi’s 2024 Global Healthcare Conference Nov 27, 2024 Read More Sensei Biotherapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights Nov 14, 2024 Read More Sensei Biotherapeutics to Present at Two Upcoming Scientific Conferences Oct 29, 2024 Read More Sensei Biotherapeutics to Present Preclinical Data on SNS-103 at the CRI-ENCI Eighth International Immunotherapy Conference Sep 04, 2024 Read More Sensei Biotherapeutics to Present at Upcoming Conferences Sep 04, 2024 Read More Sensei Biotherapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights Aug 06, 2024 Read More Sensei Biotherapeutics to Participate in Jefferies Global Healthcare Conference May 30, 2024 Read More Sensei Biotherapeutics Presents Promising Clinical Data from Phase 1 Dose Escalation Study of SNS-101 May 23, 2024 Read More Sensei Biotherapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights May 09, 2024 Read More Sensei Biotherapeutics to Present Topline Clinical Data from the SNS-101 Phase I Dose Escalation Study at the 2024 ASCO Annual Meeting Apr 24, 2024 Read More Pagination Current page 1 Page 2 Next page next › Last page last » Displaying 1 - 10 of 17
